Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of amiodarone versus esmolol in patients with septic shock
IRCT20190929044923N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of amiodarone and esmolol in septic shock (2 arms), sponsored by Tehran University of Medical Sciences. Started Dec 2019; status: completed.
02
Drugs
amiodaroneesmolol
03
Conditions
septic shock
Beyond the preview
Go deeper on IRCT20190929044923N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190929044923N1.